Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 55.54M | 48.47M | 44.05M | 40.24M | 124.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.54M | 48.47M | 44.05M | 40.24M | 124.59M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 55.54M | 48.47M | 44.05M | 40.24M | 124.59M |
| SG&A Expenses | 47.72M | 37.63M | 36.12M | 35.23M | 35.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 226.85M | 211.72M | 197.39M | 185.86M | 179.36M |
| Operating Income | -171.31M | -163.25M | -153.34M | -145.62M | -54.77M |
| Income Before Tax | -180.48M | -170.46M | -158.57M | -142.29M | -50.35M |
| Income Tax Expenses | -88.00K | -88.00K | -2.41M | -3.54M | 893.00K |
| Earnings from Continuing Operations | -180.40 | -170.37 | -156.16 | -138.74 | -51.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -180.40M | -170.37M | -156.16M | -138.74M | -51.24M |
| EBIT | -171.31M | -163.25M | -153.34M | -145.62M | -54.77M |
| EBITDA | -171.29M | -163.23M | -153.22M | -145.29M | -54.19M |
| EPS Basic | -0.79 | -0.75 | -0.69 | -0.61 | -0.23 |
| Normalized Basic EPS | -0.48 | -0.46 | -0.45 | -0.43 | -0.17 |
| EPS Diluted | -0.79 | -0.75 | -0.69 | -0.61 | -0.23 |
| Normalized Diluted EPS | -0.48 | -0.46 | -0.45 | -0.43 | -0.18 |
| Average Basic Shares Outstanding | 916.00M | 908.68M | 908.68M | 907.04M | 905.99M |
| Average Diluted Shares Outstanding | 916.00M | 908.68M | 908.68M | 907.04M | 918.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |